Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Partners
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Latest news
‘Internal effect markers’ – Take-aways from the 6th EXIMIOUS Symposium
The sixth EXIMIOUS Symposium was held online Thursday, 7 March 2024, attracting around 40 participants. This edition, titled “Internal effect markers: immune, genetics and epigenetics”, zoomed in on the topic of the impacts environmental and occupational exposures have on our health through three talks by the invited experts Dr. Unni Cecilie Nygaard (Norwegian Institute of
EXIMIOUS launches first online tool: DMP-CHECK
One of EXIMIOUS’s main objectives is to develop a toolbox catering to diverse stakeholders, facilitating their understanding and use of the project’s findings, outcomes and results. This toolbox will provide resources tailored for patients, researchers, policymakers, and decision-makers, empowering them to generate data and insights, even beyond the end of the EXIMIOUS project. EXIMIOUS has
EXIMIOUS scientific meeting 2024: advancing research on exposure-induced immune effects
Barcelona, February 22-23, 2024 In a collaborative effort to propel advancements in understanding exposure-induced immune effects, the EXIMIOUS scientific meeting took place at the esteemed Vall d’Hebron Research Institute in Barcelona from 22-23 February 2024. The event, organised and hosted by the Institute, saw participation of 40 people representing the 16 partners involved in the
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.